Aspire Biopharma Holdings, Inc. 10-Q

Accession 0001493152-23-039795

Filing information

CIK: 0001847345
Report date: 2023-09-30
Filing date: 2023-11-08
Form: 10-Q
Primary document: form10-q.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.